Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
John P. Shannon is recorded as CEO and Board Member at Xeris Biopharma Holdings, Inc. (XERS). Xeris Biopharma Holdings, Inc. reported in an 8-K filed July 8, 2024 that John P. Shannon was appointed member of the Board of Directors, effective August 1, 2024. Xeris Biopharma Holdings, Inc. reported in an 8-K filed July 8, 2024 that John P. Shannon was appointed CEO, effective August 1, 2024. The proxy statement of Xeris Biopharma Holdings, Inc. reports total compensation of $1,848,153 for John P. Shannon in fiscal 2023, including a base salary of $571,411. Disclosed compensation is on record for 3 fiscal years. John P. Shannon has spoken on 2 earnings calls across 1 company, most recently for Xeris Biopharma Holdings, Inc. on August 6, 2026.
“the Board has appointed, John P. Shannon, Xeris' President and Chief Operating Officer, as the new CEO and a member of the Board of Directors.”
“the Board has appointed, John P. Shannon, Xeris' President and Chief Operating Officer, as the new CEO and a member of the Board of Directors.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2024-08-01–present
2024-08-01–present
Start not stated–2024-04-23
Last confirmed by a filing; no departure on record
Recorded roles and call appearances connecting this person to public companies.
CEO, Board Member
2024-08-01–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | $571,411 | $1,848,153 |
| 2022 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | $549,433 | $1,530,218 |
| 2021 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | $527,500 | $1,728,640 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
